Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control study

H. Terui(Tohoku University), Kenshi Yamasaki(Tohoku University), Toshiya Takahashi(Tohoku University), Setsuya Aiba(Tohoku University), T. Ohtani(Miyoshi Kasei (Japan)), Kenichiro Tsuchiyama(Tohoku University), Akiko Hagiwara‐Takita(Tohoku University), Yoshiyuki Kusakari(Tohoku University), Ryoko Shimada‐Omori(Tohoku University), Masayuki Asano(Tohoku University), Mei Nasu‐Tamabuchi(Tohoku University)
The Journal of Dermatology
August 6, 2021
Cited by 4


Related Papers